Viremia Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting viremia clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Beijing, China, Brisbane, Queensland, Australia, Burnt Forest, Uasin Gishu County, Kenya. Updated daily from ClinicalTrials.gov.


Viremia Trials at a Glance

11 actively recruiting trials for viremia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Brisbane, and Burnt Forest. Lead sponsors running viremia studies include Columbia University, Daihong Liu, and Centre for Infectious Disease Research in Zambia.

Browse viremia trials by phase

Treatments under study

About Viremia Clinical Trials

Looking for clinical trials for Viremia? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Viremia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Viremia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

CMV ViremiaBrain Cancer Metastatic
The Methodist Hospital Research Institute28 enrolled1 locationNCT07383649
Recruiting
Phase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled12 locationsNCT05325008
Recruiting
Phase 1Phase 2

EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

Post-Transplant Lymphoproliferative DisorderEBV-DNA Viremia
Daihong Liu18 enrolled1 locationNCT07438067
Recruiting
Phase 2Phase 3

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735
Recruiting
Not Applicable

Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV

StigmatizationHIVTransmission Vertical+7 more
Indiana University200 enrolled1 locationNCT06999928
Recruiting
Not Applicable

Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania

PregnancyHIV Antiretroviral Therapy (ART) AdherencePMTCT+3 more
Karolinska Institutet222 enrolled2 locationsNCT06605053
Recruiting
Not Applicable

PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY

HIV-1-infectionHIV Viremia
Centre for Infectious Disease Research in Zambia3,000 enrolled2 locationsNCT07021092
Recruiting
Phase 4

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia120 enrolled8 locationsNCT06646562
Recruiting
Phase 1

Expansion of Virus-Specific Lymphocytes for Cell Therapy

CMV ViremiaCMV
Hospital Israelita Albert Einstein10 enrolled1 locationNCT06011486
Recruiting
Not Applicable

Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression

HIV Viremia
University of Texas, El Paso220 enrolled1 locationNCT05377463
Recruiting
Phase 2

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

CMV Viremia
University Medical Centre Ljubljana90 enrolled1 locationNCT05432778